p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression - Activation of Ras-MAP kinase and protein kinase A signaling cascades transcriptionally down-regulates caveolin-1 promoter activity

被引:150
作者
Engelman, JA
Zhang, XL
Razani, B
Pestell, RG
Lisanti, MP
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA
关键词
D O I
10.1074/jbc.274.45.32333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Caveolin-1 is a principal component of caveolae membranes in vivo. Caveolin-1 mRNA and protein expression are down-regulated in NIH 3T3 cells in response to transformation by activated oncogenes, such as H-Ras(G12V) and v-Abl, The mechanisms governing this down-regulation event remain unknown. Here, we show that caveolin-1 gene expression is directly regulated by activation of the Ras-p42/44 MAP kinase cascade, Down regulation of caveolin-1 protein expression by Ras is independent of (i) the type of activating mutation (G12V versus Q61L) and (ii) the form of activated Ras transfected (H-Ras versus H-Ras versus N-Ras), Treatment of Ras or Raf-transformed MH 3T3 cells with a well characterized MEK inhibitor (PD 98059) restores caveolin-1 protein expression. In contrast, treatment of v-Src and v-Abl transformed NIH 3T3 cells with PD 98059 does not restore caveolin-1 expression. Thus, there must be at least two pathways for down-regulating caveolin-1 expression: one that is p42/44 MAP kinase-dependent and another that is p42/44 MAP kinase-independent. We focused our efforts on the p42/44 MAP kinase-dependent pathway. The activity of a panel of caveolin-1 promoter constructs was evaluated using transient expression in H-Ras(G12V) transformed MR 3T3 cells. We show that caveolin-1 promoter activity is up-regulated similar to 5-fold by inhibition of the p42/44 MAP kinase cascade. Using electrophoretic mobility shift assays we provide evidence that the caveolin-1 promoter (from -156 to -561) is differentially bound by transcription factors in normal and H-Ras(G12V)-transformed cells. We also show that activation of protein kinase A (PKA) signaling is sufficient to down-regulate caveolin-1 protein expression and promoter activity. Thus, we have identified two signaling pathways (Ras-p42/44MAP kinase and PKA) that transcriptionally down-regulate caveolin-1 gene expression.
引用
收藏
页码:32333 / 32341
页数:9
相关论文
共 36 条
  • [1] CLONING OF A RAB3 ISOTYPE PREDOMINATELY EXPRESSED IN ADIPOCYTES
    BALDINI, G
    HOHL, T
    LIN, HY
    LODISH, HF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 5049 - 5052
  • [2] Interaction of a receptor tyrosine kinase, EGF-R, with caveolins - Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities
    Couet, J
    Sargiacomo, M
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) : 30429 - 30438
  • [3] Molecular and cellular biology of caveolae - Paradoxes and plasticities
    Couet, J
    Li, SW
    Okamoto, T
    Scherer, PE
    Lisanti, MP
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (04) : 103 - 110
  • [4] Identification of peptide and protein ligands for the caveolin-scaffolding domain - Implications for the interaction of caveolin with caveolae-associated proteins
    Couet, J
    Li, SW
    Okamoto, T
    Ikezu, T
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) : 6525 - 6533
  • [5] A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE
    DUDLEY, DT
    PANG, L
    DECKER, SJ
    BRIDGES, AJ
    SALTIEL, AR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 7686 - 7689
  • [6] Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo - A role for the caveolin-scaffolding domain
    Engelman, JA
    Chu, C
    Lin, A
    Jo, H
    Ikezu, T
    Okamoto, T
    Kohtz, DS
    Lisanti, MP
    [J]. FEBS LETTERS, 1998, 428 (03): : 205 - 211
  • [7] Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3) - Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/731)
    Engelman, JA
    Zhang, XL
    Galbiati, F
    Lisanti, MP
    [J]. FEBS LETTERS, 1998, 429 (03) : 330 - 336
  • [8] Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers
    Engelman, JA
    Zhang, XL
    Lisanti, MP
    [J]. FEBS LETTERS, 1998, 436 (03): : 403 - 410
  • [9] Molecular genetics of the caveolin gene family:: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy
    Engelman, JA
    Zhang, XL
    Galbiati, F
    Volonté, D
    Sotgia, F
    Pestell, RG
    Minetti, C
    Scherer, PE
    Okamoto, T
    Lisanti, MP
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (06) : 1578 - 1587
  • [10] Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo -: Implications for human breast cancer
    Engelman, JA
    Lee, RJ
    Karnezis, A
    Bearss, DJ
    Webster, M
    Siegel, P
    Muller, WJ
    Windle, JJ
    Pestell, RG
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) : 20448 - 20455